Clinical Trial to Evaluate the Efficacy & Safety of DA-5219 in Patients

See also
Status	Clinical Trial	Phase
Completed	`NCT05163756` - To Evaluate the Efficacy and Safety of DW1903 in Acute and Chronic Gastritis Patient	Phase 3
Completed	`NCT03443804` - To Evaluate the Efficacy and Safety of DW-1401 in Acute and Chronic Gastritis Patients	Phase 3
Active, not recruiting	`NCT04702542` - To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children.	N/A
Completed	`NCT06269380` - Evaluation of Antral Biopsies Obtained in Normal Esophagogastroduodenoscopy	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT05163756 - To Evaluate the Efficacy and Safety of DW1903 in Acute and Chronic Gastritis Patient

Phase 3

Completed

NCT03443804 - To Evaluate the Efficacy and Safety of DW-1401 in Acute and Chronic Gastritis Patients

Phase 3

Active, not recruiting

NCT04702542 - To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children.

N/A

Completed

NCT06269380 - Evaluation of Antral Biopsies Obtained in Normal Esophagogastroduodenoscopy

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT06151210
Study type	Interventional
Source	Dong-A ST Co., Ltd.
Contact	Hwoon-Yong Jung, Ph.D
Phone	+82) 02-3010-3197
Email	hwoonymd@gmail.com
Status	Recruiting
Phase	Phase 3
Start date	January 31, 2024
Completion date	December 2024

Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic Gastritis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms